Information for "Tyrosine Kinase Inhibitors as a Treating Pointing to CNS Metastases in OncogeneDriven NSCLC"

From EECH Central
Jump to: navigation, search

Basic information

Display titleTyrosine Kinase Inhibitors as a Treating Pointing to CNS Metastases in OncogeneDriven NSCLC
Default sort keyTyrosine Kinase Inhibitors as a Treating Pointing to CNS Metastases in OncogeneDriven NSCLC
Page length (in bytes)3,269
Page ID1377582
Page content languageEnglish (en)
Page content modelwikitext
Indexing by robotsAllowed
Number of redirects to this page0

Page protection

EditAllow all users (infinite)
MoveAllow all users (infinite)

Edit history

Page creatorTurretgoal73 (Talk | contribs)
Date of page creation12:30, 18 April 2024
Latest editorTurretgoal73 (Talk | contribs)
Date of latest edit12:30, 18 April 2024
Total number of edits1
Total number of distinct authors1
Recent number of edits (within past 90 days)1
Recent number of distinct authors1